Researching prurigo nodularis (PN) can be confusing because various websites offer conflicting information. Some sources suggest that PN is an autoimmune disease, while others say it’s not. Sorting through these details can make it difficult to understand your condition.
Many doctors and researchers agree that PN is not an autoimmune disease. Instead, they believe it’s caused by dysregulation or miscommunication between your immune system, skin cells, and nerves.
In this article, we’ll discuss why prurigo nodularis (also called nodular prurigo) isn’t universally considered an autoimmune disease. We’ll also cover other immune-mediated conditions — conditions involving abnormal immune system responses — that PN is related to.
By working with your dermatologist and sticking to your treatment plan, you can better control your PN and other health conditions. Keeping your PN symptoms under control can also help you improve your quality of life.
Autoimmune diseases are conditions in which your immune system attacks your body’s own healthy cells. Specifically, your immune system mistakes certain patterns as harmful. Your body then creates autoantibodies, a type of specialized protein. These autoantibodies tag your tissues for destruction, leading to troublesome symptoms.
Examples of autoimmune diseases include:
Some skin conditions like psoriasis and dermatomyositis are also autoimmune diseases. However, doctors and researchers haven’t figured out whether PN is an autoimmune disease. Instead, they think PN may be due to immune dysregulation — miscommunication between your skin, immune system, and nerve cells.
PN is a skin condition that causes intense itching or pruritus. When you pick at, rub, or scratch your skin, it creates hard lumps, known as nodules and papules. These lumps release inflammatory chemicals known as cytokines that make your skin even itchier than before. The more you itch, the more cytokines your skin releases. This creates a vicious “itch-scratch cycle” that’s hard to break.
PN is considered an inflammatory skin condition but not an autoimmune disease. This is because the immune system doesn’t attack healthy cells in PN. Researchers haven’t found any autoantibodies that play a role in PN.
Instead, many immune cells release cytokines and create inflammation. For example, mast cells release histamines, which are responsible for causing itchy skin with allergies. Other immune cells, known as T cells, also release chemicals that cause itching in other skin diseases.
Even though PN isn’t considered an autoimmune disease, it does seem to be related to other diseases that lead to immune system dysfunction. Many studies have found connections between PN and other immune-mediated or autoimmune diseases. When you have two conditions or diseases at the same time, they’re known as comorbidities.
Doctors and researchers believe that cytokines play a key role. This is because many of the cytokines involved in PN are also found in other diseases. For example, interleukin (IL)-31 causes itchy skin in PN. Researchers also believe IL-31 plays a role in dermatomyositis, an autoimmune disease that affects connective tissues.
Researchers from Korea followed 3,591 people with PN, looking for related autoimmune diseases. The authors found that people with PN are twice as likely to develop systemic lupus erythematosus (the most common type of lupus), an autoimmune disease that affects the skin, joints, and kidneys.
The authors also reported that people with PN were more likely to have:
Another study found that PN is associated with psoriasis. Like PN, psoriasis is an immune-mediated condition that causes inflammation.
Biologics are lab-made proteins used to treat a variety of diseases. Monoclonal antibody drugs are commonly used in treating autoimmune diseases to reduce inflammation and control immune system function. They’re given as subcutaneous (underneath the skin) intravenous infusions or injections. Doctors have been using biologics to treat autoimmune diseases for several years.
Dupilumab (Dupixent) was first approved by the U.S. Food and Drug Administration (FDA) in 2017 for treating atopic dermatitis. It works by blocking inflammatory molecules in the skin. Since then, dupilumab has also been approved for treating PN, asthma, and other inflammatory conditions.
Another biologic drug known as nemolizumab is currently in clinical trials. Phase 3 trials results published in October, 2023 showed that nemolizumab significantly reduced itching and improved skin clearance in people with moderate to severe prurigo nodularis. Researchers have found that the drug has a good safety profile and was well-tolerated. Common side effects include injection site reactions, headache, and worsening of atopic dermatitis. The drug is not currently approved by the FDA.
Dupilumab is the first FDA-approved treatment for PN in adults. The approval was based on two clinical trials (large studies) looking at whether dupilumab was safe and effective for treating PN.
The study participants received either dupilumab or a placebo (saline solution) every two weeks for 24 weeks total. The investigators — doctors and researchers running the study — measured the participants’ itch scores and number of nodules.
After 24 weeks, the investigators found that dupilumab treatment helped 60 percent of participants improve their skin itching scores. On the other hand, only 18.4 percent of participants taking the placebo improved their scores. This finding means that dupilumab treatment was effective for treating PN.
Another study from China found that dupilumab treatment helped people reach remission, meaning they had skin clearance and no symptoms. The authors reported that after 16 weeks of treatment:
The most common side effects of the drug, according to the FDA, include injection site reactions, common cold, muscle pain, diarrhea, and throat pain.
These studies all show promising results for treating PN with dupilumab. However, we don’t yet know how long the effects last. Over time, investigators will need to run longer studies to find out whether dupilumab helps treat PN symptoms in the long term.
If you’re living with an underlying condition or one related to PN, it’s important to get proper treatment. These conditions may be making your PN symptoms worse. By better controlling underlying conditions, you can stop the itch-scratch cycle, improve your PN symptoms, and prevent them from returning.
Many anti-inflammatory treatments used for PN also treat other autoimmune diseases. You can work closely with your dermatologist or another health care provider to find what combination of treatments works best for you.
Examples of therapies used for treating PN include:
MyPrurigoTeam is the social network for people with prurigo nodularis and their loved ones. On MyPrurigoTeam, more than 2,000 members come together to ask questions, give advice, and share their stories with others who understand life with PN.
Do you have more questions about why prurigo nodularis isn’t considered an autoimmune disease? Share them in a comment below or on your Activities page.
Get updates directly to your inbox.
What Are Other Nodularis Conditions That Are NOT Caused By Iching First? My Nodularis Produces Huge White Bumps WITH No Prior Itching?
Will This Ever Go Away, I Feel Like Pulling My Finger Nails Out. I Just Can't Keep My Hands Off Of My Face, My Buttocks Seem To Be A Little
Is It Uncommon To Have Nodular Prurigo On The Face?
Become a member to get even more:
A MyPrurigoTeam Member
I have PN and i haven't been told its autoimmune just that it was a skin condition, and i was told to start duplixent. Is duplixent the only helper ?
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.